deltatrials
Recruiting OBSERVATIONAL NCT07162675

Step Count and Treatment Response in Neoadjuvant Breast Cancer (NEOBRE-STEP)

A Multicenter Prospective Study: The Impact of Step Count Measured by Smartwatches on Treatment Response in Non-Metastatic HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Therapy

Sponsor: Ankara Etlik City Hospital

Conditions Breast Cancer Females Breast Neoplasm Malignant Female Exercise Sleep Quality Smartwatches Wearable Technology
Interventions Huawei Fit 2 Smartwatch
Updated 2 times since 2025 Last updated: Feb 19, 2026 Started: Sep 8, 2025 Primary completion: Aug 29, 2026 Completion: Aug 29, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer Females and Breast Neoplasm Malignant Female, this trial is actively recruiting participants. The trial is conducted by Ankara Etlik City Hospital and has accumulated 2 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshotRecruiting~Feb 2026 – present · 7 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting

  2. Oct 2025 — Feb 2026 [monthly]

    Recruiting

    First recorded

Sep 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ankara Etlik City Hospital
Data source: Ankara Etlik City Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations